19 Results
Sort By:
Published on March 27, 2019
Progress Is Being Made Toward Using Big Data for Genomics-Guided Precision Medicine Precision medicine springs from a paradox. On the one hand, researchers in the field seek to characterize ever smaller populations of patients—to the level of a single person (the so-called n-of-one). In that sense, “precision medicine is almost…
Published on June 20, 2018
Signaling growing interest in personalized oncology treatments as well as diagnostics, Roche plans a $2.4 billion acquisition that will expand its majority stake in Foundation Medicine into full ownership of the cancer-focused molecular diagnostics developer. Under the deal, Roche and Foundation Medicine said, they plan to combine their expertise in…
Published on April 7, 2021
Startup Orchid already has a wait list for its soon-to-be released new test to predict a child’s risk of common diseases—before conception. The test requires only a saliva sample from each prospective parent, and is based on genetic risk scores calculated by testing for genetic variations. The company also announced…
Published on November 5, 2018
Bolstered by $200 million from equity firm General Atlantic, and with the participation of three founding oncology practices, OneOncology launched in mid-September organized around technology and economies of scale to help community cancer centers operate more effectively across the continuum of care in preparation for the challenges of new value-based…